Session Information

SYM S040 - Cutaneous Oncology

Open admission to eligible categories, no tuition or ticket

Date: Monday, March 04

CME Credits: 3.00

Location: Room C220/221/222

Time: 9:00 AM - 12:00 PM

Director: Darrell S. Rigel, MD, FAAD - Handout

Speakers:

Roger I. Ceilley, MD, FAAD - Handout
Clay J. Cockerell, MD, FAAD - Handout
Laura K. Ferris, MD, PhD, FAAD
Robert J. Friedman, MD
Sancy A. Leachman, MD, PhD, FAAD
Mark Lebwohl, MD, FAAD - Handout
Theodore Rosen, MD, FAAD
Abel Torres, MD, JD, FAAD - Handout
Steven Q. Wang, MD, FAAD
Martin A. Weinstock, MD, PhD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

Identify and better respond to the typical issues that arise in skin cancer management
Provide the best patient care to patients with skin cancer
Best assess the risk factors and prognosis for skin cancer

Description:
The most important management issue that we face on a daily basis in dermatology from a life-and-death perspective is skin cancer. In the past decade, dermatologists have evolved from merely diagnosing skin cancer to being actively involved in all phases of management. It is therefore incumbent upon us to be up to date on all aspects of cutaneous oncology. The goal of this symposium is to provide the most up-to-date information on melanoma to the practicing dermatologist so that our responses to the issues that we deal with in skin cancer on a daily basis can be optimized.

References:

Cancer of the Skin. Rigel et al eds. Elsevier Publishing, 2011.

Schedule:

Monday, March 04
9:00 AM	Introduction and review of today's session / Dr. Rigel
9:05 AM	Which Makes More Sense for Treating AKS – Field or Lesional Therapy? / Dr. Rosen
9:20 AM	Does Sunscreen Usage Lower the Risk for Skin Cancer? / Dr. Ceilley
9:35 AM	Do Sunscreen Ingredients Put the User at Risk? / Dr. Wang
9:50 AM	Do Psoriasis Therapies put Patients at Increased Risk for Skin Cancer? / Dr. Lebwohl
10:05 AM	Should the Management of Dysplastic Nevi be Focused on Precursor or Marker Implications? / Dr. Cockerell
10:20 AM	Q and A / Dr. Rigel, Dr. Ceilley, Dr. Rosen, Dr. Wang, Dr. Lebwohl, and Dr. Cockerell
10:35 AM	Do Devices have a significant impact on Melanoma Diagnosis? / Dr. Ferris
10:50 AM	Melanoma Prevention Strategies – Should we focus on Primary or Secondary Prevention strategies? / Dr. Weinstock
11:05 AM	Is it Time for Genetic Testing in Melanoma – Why When and Who? / Dr. Leachman
11:20 AM	How Effective are the Newer Medical Therapies for Advanced Skin Cancer? / Dr. Torres
11:35 AM	Does Sentinel Node Biopsy Impact Melanoma Survival in Melanoma Patients? / Dr. Friedman
11:50 AM	Q and A / Dr. Friedman, Dr. Ferris, Dr. Swetter, Dr. Leachman, and Torres